RCELNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31Also trades as AVHHL
AVITA Medical, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$13.14+0.10 (+0.77%)
Close on Oct 19, 2026
- Market cap
- $404.05M
- P/E (TTM)
- –
- Dividend yield
- –
AVITA Medical statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | AVITA Medical | Industry median |
|---|---|---|
| Market Cap | $406.38M | $229.23M |
| Enterprise Value | $441.94M | $194.73M |
| PS Ratio | 5.37 | 3.14 |
Enterprise value
| Measure | AVITA Medical | Industry median |
|---|---|---|
| EV / Sales | 5.84 | 2.93 |
Income (trailing twelve months)
| Measure | AVITA Medical | Industry median |
|---|---|---|
| Revenue | $75.63M | $102.39M |
| Gross Profit | $61.68M | $60.36M |
| Operating Income | -$35.22M | -$4.31M |
| Pretax Income | -$43.06M | -$2.26M |
| Net Income | -$43.08M | -$6.57M |
| EBITDA | -$32.71M | -$1.98M |
| EPS (Diluted) | -$1.44 | -$0.07 |
Margins
| Measure | AVITA Medical | Industry median |
|---|---|---|
| Gross Margin | 81.6% | 55.1% |
| Operating Margin | -46.6% | -6.04% |
| Pretax Margin | -56.9% | -4.11% |
| Profit Margin | -57.0% | -10.5% |
| EBITDA Margin | -43.3% | -2.67% |
| FCF Margin | -32.5% | -0.30% |
Returns
| Measure | AVITA Medical | Industry median |
|---|---|---|
| Return on Assets (ROA) | -81.4% | -13.3% |
| Return on Invested Capital (ROIC) | -260.7% | -4.11% |
Growth
| Measure | AVITA Medical | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 1.00% | 8.85% |
| Revenue Growth (3Y CAGR) | 34.8% | 7.08% |
| Revenue Growth (5Y CAGR) | 67.2% | 11.8% |
Balance sheet
| Measure | AVITA Medical | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $11.10M | $37.33M |
| Total Debt | $46.66M | $72.66M |
| Net Cash (Debt) | -$35.56M | $3.92M |
| Net Cash Per Share | -$1.15 | $0.28 |
| Equity (Book Value) | -$27.84M | $57.36M |
| Book Value Per Share | -$0.90 | $2.81 |
| Tangible Book Value | -$33.09M | $10.71M |
| Working Capital | -$40.32M | $54.64M |
Financial position
| Measure | AVITA Medical | Industry median |
|---|---|---|
| Current Ratio | 0.41 | 2.50 |
| Quick Ratio | 0.31 | 1.54 |
| Interest Coverage | -6.52 | -1.81 |
Cash flow (trailing twelve months)
| Measure | AVITA Medical | Industry median |
|---|---|---|
| Operating Cash Flow | -$24.23M | -$653.46K |
| Capital Expenditures | -$387.00K | -$3.69M |
| Free Cash Flow | -$24.62M | -$835.02K |
| FCF Per Share | -$0.80 | -$0.02 |
Efficiency
| Measure | AVITA Medical | Industry median |
|---|---|---|
| Asset Turnover | 1.43 | 0.59 |
| Inventory Turnover | 2.18 | 2.21 |
| Revenue Per Employee | $334.65K | $322.75K |
| Profits Per Employee | -$190.63K | -$52.11K |
| Employee Count | 226 | 197 |
Dividends and yields
| Measure | AVITA Medical | Industry median |
|---|---|---|
| Earnings Yield | -10.6% | -6.92% |
| FCF Yield | -6.06% | -0.62% |
Shares
| Measure | AVITA Medical | Industry median |
|---|---|---|
| Shares Outstanding | 30,926,800 | 44,856,700 |
| Shares Change (YoY) | 14.6% | 3.35% |
| Shares Change (QoQ) | 0.49% | 0.27% |
| Float | 30,090,900 | 36,934,400 |
| Shares Held by Insiders | 2.70% | 10.6% |
| Shares Held by Institutions | 15.9% | 63.5% |
Taxes
| Measure | AVITA Medical | Industry median |
|---|---|---|
| Income Tax | $20.00K | $1.52M |
Scores
| Measure | AVITA Medical | Industry median |
|---|---|---|
| Altman Z-Score | -11.14 | 1.95 |
| Piotroski F-Score | 3 | 5 |
| Beneish M-Score | -4.09 | -2.64 |
Calculated by StockData from AVITA Medical's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.